105.44
+1.53(+1.47%)
Currency In USD
| Previous Close | 103.91 |
| Open | 104.99 |
| Day High | 106.63 |
| Day Low | 103.96 |
| 52-Week High | 139.13 |
| 52-Week Low | 72.21 |
| Volume | 245,787 |
| Average Volume | 697,219 |
| Market Cap | 5.19B |
| PE | -18.27 |
| EPS | -5.77 |
| Moving Average 50 Days | 106.69 |
| Moving Average 200 Days | 103.03 |
| Change | 1.53 |
If you invested $1000 in Axsome Therapeutics, Inc. (AXSM) since IPO date, it would be worth $12,064.07 as of July 06, 2025 at a share price of $105.44. Whereas If you bought $1000 worth of Axsome Therapeutics, Inc. (AXSM) shares 5 years ago, it would be worth $1,285.7 as of July 06, 2025 at a share price of $105.44.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Axsome Therapeutics Champions Brain Health During Alzheimer's & Brain Awareness Month
GlobeNewswire Inc.
Jun 20, 2025 11:00 AM GMT
NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today is joining with the Alzheimer’s disease advocacy c
Axsome Therapeutics to Present Data Spanning the SYMBRAVO® (meloxicam and rizatriptan) Clinical Program at the 67th Annual Scientific Meeting of the American Headache Society (AHS)
GlobeNewswire Inc.
Jun 18, 2025 11:00 AM GMT
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that data from across the SYMBRAVO® (mel
Axsome Therapeutics Proudly Supports Migraine and Headache Awareness Month Alongside the Association of Migraine Disorders
GlobeNewswire Inc.
Jun 16, 2025 11:00 AM GMT
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, is proud to recognize Migraine and Headache Awareness Mo